
To assess baseline zzso zzso control, and treatment with oral zzso drugs zzso in type 2 diabetes zzso zzso zzso 

This zzso zzso study recruited patients zzso 21 years of age who were newly diagnosed and/or treated with zzso zzso for zzso months but were zzso zzso In zzso phase, data on zzso medical history, diabetic complications and zzso zzso treatment, zzso zzso zzso and zzso blood zzso zzso were zzso In zzso phase evaluating zzso follow-up of zzso zzso patients, additional data on reasons for not achieving zzso targets were zzso 

Of zzso patients zzso zzso zzso age zzso zzso zzso years; zzso zzso mean zzso zzso zzso zzso zzso ) zzso zzso were newly zzso zzso had central zzso zzso had hypertension, and zzso had zzso The mean zzso was zzso zzso zzso and the mean zzso was zzso zzso zzso zzso At zzso zzso and zzso zzso 6 zzso zzso zzso and zzso zzso patients received zzso zzso There was decrease from zzso to zzso in mean zzso zzso vs zzso zzso zzso and mean zzso zzso vs zzso zzso zzso zzso Number of patients with zzso zzso increased from zzso zzso to zzso zzso zzso for not achieving target zzso included poor diabetes education zzso zzso to zzso zzso and fear of zzso zzso 

zzso reductions in zzso and zzso are achievable in zzso patients managed with zzso However, patient education and compliance are important for achieving and maintaining treatment zzso 

